VEGFA and colorectal carcinoma: Despite the introduction of new molecular subdivisions (CMS1–4), advanced CRC is treated systemically with chemotherapy (e.g., FOLFOX) supplemented with anti-EGFR and anti-VEGF targeted therapy7.